Sun Pharmaceutical Industries Limited (SUNPHARMA) Share Analysis
NSE · Healthcare · Pharmaceuticals
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 100, NIFTY 200, NIFTY 50. As of 21 Sep 2026, the share price was ₹1,837.00, market capitalisation ₹4,40,830 Cr, P/E 34.9, ROE 16%.
Get the AI verdict on SUNPHARMA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
SUNPHARMA price and valuation
- Share price
- ₹1,837.00
- Market cap
- ₹4,40,830 Cr
- P/E ratio
- 34.9
- P/B ratio
- 5.28
- EPS
- ₹50.41
- Book value per share
- ₹348.00
- Dividend yield
- 0.87%
SUNPHARMA profitability and growth
- ROE
- 16%
- ROCE
- 20.5%
- Debt to equity
- 0.06
- Revenue growth (3 yr)
- 10%
- Revenue growth (5 yr)
- 12%
- Profit growth (3 yr)
- 13%
- Profit growth (5 yr)
- 17%
SUNPHARMA 52-week range
- 52-week high
- ₹2,046.90
- 52-week low
- ₹1,548.00
- Face value
- ₹1.00
SUNPHARMA shareholding pattern
- Promoters
- 54.48%
- FIIs
- 14.54%
- DIIs
- 22.06%
- Public
- 8.81%
Index membership: NIFTY 100, NIFTY 200, NIFTY 50, NIFTY 500, NIFTY Healthcare Index, NIFTY Pharma, NIFTY Quality 30.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.